Scinovex
reviewTop 1% cited

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

European Journal of Medicinal Chemistry · 2016 · Vol. 109 · pp. 314–341
Vivek AsatiDebarshi Kar MahapatraSanjay Kumar Bharti
PI3K/AKT/mTOR signaling in cancerMelanoma and MAPK PathwaysSynthesis and biological activityPI3K/AKT/mTOR pathwayProtein kinase BMAPK/ERK pathwaySignal transductionKinaseCancer researchCarcinogenesisChemistryPhosphorylationCell biology

MeSH terms

AnimalsAntineoplastic AgentsEnzyme InhibitorsHumansNeoplasmsSignal Transductionras ProteinsPhosphatidylinositol 3-KinasesMAP Kinase Signaling Systemraf KinasesProto-Oncogene Proteins c-aktDrug DiscoveryTOR Serine-Threonine Kinases

Funding

  • Indian Council of Medical Research
Citations
607
FWCI
23.32
field-weighted impact
References
158
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.